Claritev Corp (CTEV) stock
CTEVNYSEServices-Business Services, NECFiscal year ends December 31
$26.90−1.31 (-4.64%)
Close on Nov 12, 2026Market cap $455.89MP/E –Yield –
Claritev EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Claritev's EPS for the twelve months ending Sep 30, 2026 was -$16.41. For fiscal 2025 it was -$17.30. The highest annual figure on record is $6.40 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.30 | – |
| FY2024 | Dec 31, 2024 | -$101.92 | – |
| FY2023 | Dec 31, 2023 | -$5.69 | – |
| FY2022 | Dec 31, 2022 | -$36.00 | -662.5% |
| FY2021 | Dec 31, 2021 | $6.40 | – |
| FY2020 | Dec 31, 2020 | -$44.40 | -5650.0% |
| FY2019 | Dec 31, 2019 | $0.80 | -77.8% |
| FY2018 | Dec 31, 2018 | $3.60 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$3.64 | – |
| Q2 FY2026 | Jun 30, 2026 | -$3.49 | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.41 | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.87 | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.23 | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.81 | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.38 | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.53 | – |
| Q3 FY2024 | Sep 30, 2024 | -$24.25 | – |
| Q2 FY2024 | Jun 30, 2024 | -$35.78 | – |
| Q1 FY2024 | Mar 31, 2024 | -$33.40 | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.93 | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.49 | -224.2% |
| Q2 FY2023 | Jun 30, 2023 | -$2.40 | -400.0% |
| Q1 FY2023 | Mar 31, 2023 | $0.00 | -100.0% |
| Q4 FY2022 | Dec 31, 2022 | -$40.83 | -2734.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.20 | -75.0% |
| Q2 FY2022 | Jun 30, 2022 | $0.80 | – |
| Q1 FY2022 | Mar 31, 2022 | $2.80 | 0.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.55 | – |
| Q3 FY2021 | Sep 30, 2021 | $4.80 | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.80 | – |
| Q1 FY2021 | Mar 31, 2021 | $2.80 | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.80 | -1000.0% |
| Q3 FY2020 | Sep 30, 2020 | -$27.60 | -7000.0% |
| Q2 FY2020 | Jun 30, 2020 | -$5.60 | – |
| Q1 FY2020 | Mar 31, 2020 | -$0.40 | – |
| Q4 FY2019 | Dec 31, 2019 | $1.20 | – |
| Q3 FY2019 | Sep 30, 2019 | $0.40 | – |
| Q2 FY2019 | Jun 30, 2019 | $0.00 | – |
| Q1 FY2019 | Mar 31, 2019 | -$0.80 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?